Response to: Skin reactions to mRNA-1273 SARS-CoV-2 vaccine
QJM
.
2022 Dec 12;115(12):879.
doi: 10.1093/qjmed/hcac010.
Authors
Y Kano
1
2
,
S Kasami
1
,
K Murata
3
,
M Kato
1
Affiliations
1
Department of Dermatology, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, Japan.
2
Department of General Internal Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, Japan.
3
Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8524, Japan.
PMID:
35038737
DOI:
10.1093/qjmed/hcac010
No abstract available
Publication types
Comment
MeSH terms
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
SARS-CoV-2
Substances
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines